IMEDICARE Trademark Information

Trademark by Flavma, Inc.

Software as a service, namely, providing a platform that provides patients and pharmacists with information and costs for drugs, healthcare and healthcare plans; software as a service, namely, providing a platform that provides personal patient health profiles used to generate comparative healthcare plan, drug and costs analyses; software as a service, namely, a platform that provides information to healthcare plans and access to enrollment of...

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: 1/12/2012
First Use In Commerce: 1/12/2012
General Information
Word mark: IMEDICARE
Status/Status Date:
CONTINUED USE AND INCONTESTIBILITY ACCEPTED
6/1/2021
Serial Number: 85886894
Filing Date: 3/26/2013
Registration Number: 4633198
Registration Date: 11/4/2014
Goods and Services: Software as a service, namely, providing a platform that provides patients and pharmacists with information and costs for drugs, healthcare and healthcare plans; software as a service, namely, providing a platform that provides personal patient health profiles used to generate comparative healthcare plan, drug and costs analyses; software as a service, namely, a platform that provides information to healthcare plans and access to enrollment of healthcare plans; software as a service, namely, a platform that provides healthcare information and access to insurance brokerage services
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 4/1/2014
Last Applicant/Owner:
Flavma, Inc.
********
********
***** ****
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
CONTINUED USE AND INCONTESTIBILITY ACCEPTED
6/1/2021
Correspondent Search:
Michelle Rosenberg is a correspondent of IMEDICARE trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on